Literature DB >> 2384111

Association between false negative hepatobiliary scans and initial gallbladder visualization after 30 min.

R J Hicks1, M J Kelly, V Kalff.   

Abstract

We have reviewed the experience of our institution and the literature concerning the use of hepatobiliary scintigraphy for the diagnosis of acute cholecystitis. The aim of this study was to assess whether the hepatobiliary scintigraphic finding of initial gallbladder visualization within 30 min is a more reliable criterion for excluding acute cholecystitis than gallbladder visualization within 1 h after tracer injection. In our institution's consecutive series, 113 of 211 hepatobiliary studies had gallbladder visualization within 1 h. Gallbladder visualization time in this group had a log normal distribution, with gallbladder visualization occurring within 30 min in 107 of 113 (95%). Gallbladder visualization occurred between 31 and 60 min in only 6 (5%); nevertheless, our one false negative study came from this small subgroup of patient studies (P = 0.05). Review of the literature (1645 patients with iminodiacetic acid [99mTc-IDA] derivative studies) revealed 6 further timed false negative results with gallbladder visualization within 1 h. Of these studies, in 4 (67%) the gallbladder was visualized between 31 and 60 min and in only 2 before 30 min. One of these latter 2 patients had a rare anatomy. Analysis of the pooled institutional and literature data gave an estimated false negative rate of 21% if the gallbladder was visualized between 31 and 60 min. This was significantly higher (P less than 0.001) than the 0.5% false negative rate when the gallbladder was seen prior to 30 min, but similar to the false negative rate of 16% reported by Weissmann et al. for studies with initial visualization after 1 h.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2384111     DOI: 10.1007/bf00998183

Source DB:  PubMed          Journal:  Eur J Nucl Med        ISSN: 0340-6997


  29 in total

1.  Accuracy of the hepatobiliary scan in acute cholecystitis.

Authors:  S Cabellon; J M Brown; D G Cavanaugh
Journal:  Am J Surg       Date:  1984-11       Impact factor: 2.565

2.  A sign of symptomatic chronic cholecystitis on biliary scintigraphy.

Authors:  W Al-Sheikh; M Hourani; J S Barkin; L P Clarke; F S Ashkar; A N Serafini
Journal:  AJR Am J Roentgenol       Date:  1983-02       Impact factor: 3.959

3.  Cholecystitis: prospective evaluation of sonography and 99mTc-HIDA cholescintigraphy.

Authors:  N J Worthen; J M Uszler; J L Funamura
Journal:  AJR Am J Roentgenol       Date:  1981-11       Impact factor: 3.959

4.  A surgeon's view of hepatobiliary scintigraphy.

Authors:  M L Gliedman; P J Wilk
Journal:  Semin Nucl Med       Date:  1982-01       Impact factor: 4.446

5.  Nonvisualization of the gallbladder by 99mTc-HIDA cholescintigraphy as evidence of cholecystitis.

Authors:  P Paré; E A Shaffer; L Rosenthall
Journal:  Can Med Assoc J       Date:  1978-02-18       Impact factor: 8.262

6.  Two false-negative results using morphine sulfate in hepatobiliary imaging.

Authors:  J M Mack; J D Slavin; R P Spencer
Journal:  Clin Nucl Med       Date:  1989-02       Impact factor: 7.794

7.  Rapid and accurate diagnosis of acute cholecystitis with 99mTc-HIDA cholescintigraphy.

Authors:  H S Weissmann; M S Frank; L H Bernstein; L M Freeman
Journal:  AJR Am J Roentgenol       Date:  1979-04       Impact factor: 3.959

8.  Hepatobiliary scintigraphy. Increasing the accuracy of the preoperative diagnosis of acute cholecystitis.

Authors:  G M Bednarz; V Kalff; M J Kelly
Journal:  Med J Aust       Date:  1986-10-06       Impact factor: 7.738

9.  The normal fasting and postprandial diisopropyl-IDA Tc 99m hepatobiliary study.

Authors:  W C Klingensmith; V M Spitzer; A R Fritzberg; C C Kuni
Journal:  Radiology       Date:  1981-12       Impact factor: 11.105

10.  99mTc-PIPIDA cholescintigraphy in the diagnosis of gallbladder disease.

Authors:  P R Rosen; T W Rusing; M L Nusynowitz; M L Lecklitner
Journal:  Am J Med Sci       Date:  1982 Nov-Dec       Impact factor: 2.378

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.